Other content in this Stream
Electronic prescribing of controlled substances will be required for Texas physicians beginning January 1, 2021.
Learn about the Texas Prescription Monitoring Program and how to comply with pain management legislation passed in 2019.
Physicians in Texas must now meet two new CME requirements.
TMB releases rules for PMP checks, acute pain prescribing limits, and opioid CME requirements
The TMB is trying to clear up confusion about the new 10-day opioid prescribing limit for acute pain.
State requirements for chronic pain patients have been suspended by Governor Abbott until May 1, 2021
TMB issued guidance stating that checking the PMP is NOT required for inpatient care.
The requirement for Texas physicians to check the Texas Prescription Monitoring Program before prescribing certain controlled substances has been delayed until March 20.
Managing opioids: claims analysis and case study; Wernicke’s encephalopathy after bariatric surgery; How to dismiss without abandoning: Ending the physician-patient relationship; Addressing transgende
New legislation places a 10-day limit on opioid prescriptions for acute pain.
Physicians must check the PMP beginning March 1, 2020
New guidance from the U.S. Department of Health and Human Services (HHS) provides clarification and advice for physicians on appropriate tapering methods for patients with long-term opioid use.
CDC guidelines for prescribing opioids to chronic pain patients. These guidelines apply to physicians treating patients outside the context of cancer, palliative, and end-of-life care.
For this year’s spring CME seminars, attorney Brett B. Rowe presented “How to Fight the Opioid Epidemic” in Austin and Houston. Here’s a brief recap with five risk management takeaways for physicians.
Texas physicians will soon be required to check the Texas Prescription Monitoring database before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol.
The FDA is requiring safety labeling changes to limit the use of prescription cough and cold medicines containing opioids in patients younger than 18 years old.
On October 27, the HHS Office for Civil Rights issued guidance on how HIPAA allows information sharing to respond to the opioid crisis.